+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Liquid Biopsy"

Cancer Biomarkers Market in Germany - Product Thumbnail Image

Cancer Biomarkers Market in Germany

  • Report
  • December 2025
  • 150 Pages
  • Germany
From
Cancer Biomarkers Market in India - Product Thumbnail Image

Cancer Biomarkers Market in India

  • Report
  • November 2025
  • 150 Pages
  • India
From
Cancer Biomarkers Market in Japan - Product Thumbnail Image

Cancer Biomarkers Market in Japan

  • Report
  • November 2025
  • 150 Pages
  • Japan
From
From
From
From
Cancer Biomarkers Market in China - Product Thumbnail Image

Cancer Biomarkers Market in China

  • Report
  • November 2025
  • 150 Pages
  • China
From
From
Kuwait Predictive Biomarkers Market - Product Thumbnail Image

Kuwait Predictive Biomarkers Market

  • Report
  • October 2025
  • 90 Pages
  • Kuwait
From
From
Artificial Intelligence Markets in IVD - Product Thumbnail Image

Artificial Intelligence Markets in IVD

  • Report
  • April 2020
  • 71 Pages
  • Global
From
UAE In Vitro Diagnostics Market, By Region, Competition, Forecast & Opportunities, 2019-2029F - Product Thumbnail Image

UAE In Vitro Diagnostics Market, By Region, Competition, Forecast & Opportunities, 2019-2029F

  • Report
  • October 2024
  • 85 Pages
  • United Arab Emirates United Arab Emirates
From
Loading Indicator

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions. The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests. Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more